LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

Search

Assertio Holdings Inc

Cerrado

0.62 1.64

Resumen

Variación precio

24h

Actual

Mínimo

0.62

Máximo

0.63

Métricas clave

By Trading Economics

Ingresos

-3.1M

-14M

Ventas

-5.7M

26M

BPA

-0.04

Margen de beneficios

-51.121

Empleados

58

EBITDA

-10M

-13M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+344.44% upside

Dividendos

By Dow Jones

Próximas Ganancias

6 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

4.4M

63M

Apertura anterior

-1.02

Cierre anterior

0.62

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Assertio Holdings Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

13 jun 2025, 22:33 UTC

Adquisiciones, fusiones, absorciones

Millicom to Acquire Telefonica Ecuador for $380 Million

14 jun 2025, 01:24 UTC

Adquisiciones, fusiones, absorciones

Nippon to Close U.S. Steel Deal After National-Security Pact With Trump -- 3rd Update

13 jun 2025, 23:50 UTC

Adquisiciones, fusiones, absorciones

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- 2nd Update

13 jun 2025, 23:20 UTC

Adquisiciones, fusiones, absorciones

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- Update

13 jun 2025, 23:09 UTC

Adquisiciones, fusiones, absorciones

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- WSJ

13 jun 2025, 23:03 UTC

Adquisiciones, fusiones, absorciones

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal --WSJ

13 jun 2025, 22:18 UTC

Adquisiciones, fusiones, absorciones

Millicom to Acquire Telefonica Ecuador for $380M

13 jun 2025, 22:04 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Better Data Facilitate Investments In Oil Patch -- Market Talk

13 jun 2025, 21:42 UTC

Adquisiciones, fusiones, absorciones

Anne Wojcicki Wins Bidding for 23andMe -- 2nd Update

13 jun 2025, 21:35 UTC

Adquisiciones, fusiones, absorciones

Bunge: Outside Date Extended to July 3

13 jun 2025, 21:35 UTC

Adquisiciones, fusiones, absorciones

Bunge: Subject to Satisfaction of Remaining Conditions, Bunge and Sellers Expect to Complete Transaction July 2

13 jun 2025, 21:34 UTC

Adquisiciones, fusiones, absorciones

Bunge Gets Mexico Approval for Viterra Deal

13 jun 2025, 21:32 UTC

Adquisiciones, fusiones, absorciones

Bunge Gets China Approval for Viterra Deal

13 jun 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

13 jun 2025, 20:45 UTC

Adquisiciones, fusiones, absorciones

23andMe: TTAM Makes Binding Commitments for Additional Consumer Protections and Privacy Safeguards

13 jun 2025, 20:34 UTC

Adquisiciones, fusiones, absorciones

Anne Wojcicki Wins Bidding for 23andMe -- Update

13 jun 2025, 20:14 UTC

Adquisiciones, fusiones, absorciones

Nonprofit Controlled By 23andMe Co-Founder Anne Wojcicki Would Buy the DNA-Testing Company for $305 Million -- WSJ

13 jun 2025, 20:14 UTC

Adquisiciones, fusiones, absorciones

Anne Wojcicki Wins Bidding for 23andMe -- WSJ

13 jun 2025, 20:14 UTC

Adquisiciones, fusiones, absorciones

Regeneron Walks Away From 23andMe Acquisition After Wojcicki's Higher Bid -- WSJ

13 jun 2025, 19:30 UTC

Charlas de Mercado

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

13 jun 2025, 19:12 UTC

Charlas de Mercado

Oil Futures Jump As Israel Strikes Iranian Targets -- Market Talk

13 jun 2025, 19:04 UTC

Charlas de Mercado

Canada Military Spending Hike to Lift Long-Term Yields -- Market Talk

13 jun 2025, 18:54 UTC

Charlas de Mercado

Correction to Gold Settles Market Talk

13 jun 2025, 18:01 UTC

Charlas de Mercado

Gold Settles at Record High -- Market Talk

13 jun 2025, 17:40 UTC

Charlas de Mercado

U.S. Oil Rig Count Falls By 3 to 439 -- Market Talk

13 jun 2025, 17:21 UTC

Charlas de Mercado

Dollar Index, Commodities Rise -- Market Talk

13 jun 2025, 17:02 UTC

Adquisiciones, fusiones, absorciones

Advent Proposal Values Spectris at GBP37.63 Per Share, Company Said Monday -- WSJ

13 jun 2025, 17:02 UTC

Adquisiciones, fusiones, absorciones

KKR Is Preparing a Bid for High-Tech Instrument Maker Spectris, Sources Say -- WSJ

13 jun 2025, 17:02 UTC

Adquisiciones, fusiones, absorciones

Private-Equity Firm Is Vying With Advent for the U.K. Company, Sources Say -- WSJ

13 jun 2025, 17:02 UTC

Adquisiciones, fusiones, absorciones

KKR Making Competing Bid for Equipment Maker Spectris -- WSJ

Comparación entre iguales

Cambio de precio

Assertio Holdings Inc previsión

Precio Objetivo

By TipRanks

344.44% repunte

Estimación a 12 Meses

Media 2.8 USD  344.44%

Máximo 3.5 USD

Mínimo 1.5 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Assertio Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

5 ratings

4

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

0.618 / 0.649Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Weak Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Assertio Holdings Inc

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.